-
Luspatercept’s Benefit in MDS: Dr Garcia-Manero on COMMANDS Trial
07 Jul 2025 14:46 GMT
… a major shift in the treatment approach for erythropoiesis-stimulating … a phase 3 trial comparing luspatercept vs epoetin alfa. Luspatercept is … not measure this in clinical trials, so we have to … And they are great drugs. These drugs really help our patients …
-
COMMANDS and ELEMENT-MDS Trials: Long-Term Analysis, Survival, Duration of Response, and Hemoglobin Levels
24 Jun 2025 17:22 GMT
… a phase 3 trial comparing luspatercept with epoetin alfa in … escalation or standard-dose epoetin, with treatment continuing until disease … . The ongoing ELEMENT-MDS trial, also highlighted briefly, is … the same agents. This trial aims to determine whether …
-
Self-Administered Subcutaneous Isatuximab May Ease Multiple Myeloma Treatment Burden: Xavier Leleu, MD, PhD
26 Jun 2025 01:29 GMT
… of the phase 3 IRAKLIA trial (NCT05405166), which Leleu … patients. The future of the treatment [of] cancer, when a … drug, like G-CSF [granulocyte colony-stimulating factor], like EPO [epoetin … subcutaneous formulation manual push drugs that we inject into …
-
Real-World Treatment Patterns, Clinical Outcomes, and Costs in Patients with Higher-Risk Myelodysplastic Syndromes Across France, Germany, and the United Kingdom
24 Jun 2025 14:26 GMT
… deferasirox, deferiprone, darbepoetin, epoetin, granulocyte colony-stimulating factor … treatment costs, while the first-line drug … compared with clinical trials. It is also … Medicines Corporation; speakers’ bureau for Astellas Pharma, Jazz Pharmaceuticals …
-
Promising Treatment To Raise the Standard of Care in Lower-Risk MDS-Related Anemia
30 May 2025 20:59 GMT
… it’s important for doctors to regularly monitor their … treatment.
The most common treatment-emergent adverse events observed in the COMMANDs trial … rats. When a drug is present in animal … et al. Luspatercept versus epoetin alfa in erythropoiesis-stimulating …
-
Bristol Myers Squibb to Present Data at ASCO® 2025 Highlighting Differentiated Research Platform of Oncology Treatments and Innovative Research Pipeline
22 May 2025 21:28 GMT
… vs epoetin alfa (EA) in the COMMANDS trial
Guillermo Garcia … -cel) pivotal clinical trials and real-world experience … access to BMS medicines during their treatment journey. BMS … development and commercialization of pharmaceutical products. All statements that …
-
Comparative efficacy of epoetin alfa vs. darbepoetin in children with chronic kidney disease: a systematic review, meta-analysis and cost-effectiveness analysis.
12 May 2025 05:19 GMT
Nicola Bertazza Partigiani
Pediatric Nephrology, Department of Women’s and Children’s Health, University Hospital of Padua, Padua, Italy. nicola.bertazzapartigiani@aopd.veneto.it.
University of Padua, Padua, Italy. nicola.bertazzapartigiani@aopd.veneto.it. …
-
Genetic Insights and Novel Trial Designs Contribute to an Era of Individualized MDS Management
14 May 2025 03:20 GMT
… the phase 3 IMerge trial (NCT02598661), in which … as a professor in medicine & oncologic sciences … does poorly [with treatment]. Unfortunately, most trials have not shown … ;www.fda.gov/drugs/;resources-information-approved-drugs/fda-approves- …
-
Full list of drugs that could be slashed under Trump's new executive order
13 May 2025 09:11 GMT
… narrowly covered Medicare Part B drugs, including immunosuppressants … (far right)
Cancer Treatments (Chemotherapy & Immunotherapy … 58 percent
7. Procrit
- Cost per dose … systems negotiate drug prices directly with pharmaceutical companies, bypassing …
-
Improving Quality of Life in LR-MDS Through Anemia Treatment
19 Apr 2025 02:57 GMT
… MD
Hematologist/Medical Oncologist
Rocky Mountain Cancer … to consider treatment for.
Which treatment options are … long time, including epoetin alfa and darbepoetin alfa … Genentech, Inc., GlaxoSmithKline, Novartis Pharmaceuticals Corp., OncoVerity, Inc., and …
About
© 1995-2025